• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Iron Overload

Iron Overload - 12 Studies Found

Completed : MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions.
: Iron Overload
: 2008-02-25
Completed : Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload
: Transfusional Iron Overload
: 2005-10-14
: Drug: Deferasirox Other Name: ICL670
Completed : Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload
: Iron Overload
: 2008-04-02
: Drug: Deferasirox Other Name: ICL670
Completed : Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia
: Iron Overload
: 2011-11-10
: Drug: Desferasirox Initial Dose: 20 mg/kg/d. Dose modification according to protocol.
Completed : A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload
: Transfusion-dependent Iron Overload
: 2005-09-13
: Drug: Deferasirox Other Name: ICL670
Completed : An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload
: Transfusional Iron Overload in β-thalassemia
: 2005-09-12
: Drug: Deferasirox Tablets taken orally once a day.
Completed : Cytochrome P450 2E1 and Iron Overload
:
  • Insulin Resistance
  • Iron Overload

: 2005-08-29
: Procedure: venesection Venesection therapy is realised every 7 - 14 days until iron desaturation complet
Completed : Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients
:
  • Insulin Resistance
  • Iron Overload

: 2011-05-17
:
  • Procedure: phlebotomy 7 ml/kg

Completed : Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major
:
  • Thalassemia
  • Iron Overload

: 2011-07-11
: Drug: Amlodipine 5mg PO initially; may be reduced to 2.5mg PO if side effects
Completed : Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload
:
  • Transfusional Iron Overload
  • Beta-thalassemia

: 2009-12-23
: Drug: FBS0701 Oral FBS0701 for 7 days at one of the following doses: 3 mg/kg/day or 8 mg/kg/day or 16 mg
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.